Changemakers in
Clinical Data Management: Fortrea
Innovation and Agility
As a global CRO, Fortrea continually seeks efficient and cost-effective solutions to get the best results for its pharmaceutical and biotechnology partners. By choosing a modern EDC system, they were able to cut their study build times, streamline their operations, and make mid-study amendments easily, resulting in significant efficiency gains, time savings, and increased organizational agility.
Strategies for Today’s Complex Clinical Trials
Learn how Fortrea is evolving their people, processes, and technologies to address the data complexities of today’s
adaptive and decentralized trials. Register for their upcoming webinar here
"Eliminating custom programming by using a new technology like Veeva EDC spares resources and is a huge time saver for us. And this is on the first study; it's right out of the gate.”
- Bireshwar Saha, Fortrea
Hear from other Changemakers:
Shorter Builds
GSK partnered with Veeva EDC and found they could cut their build times by half across their entire portfolio.
In addition to EDC, GSK is also pioneering in the areas of data aggregation and cleaning with Veeva CDB.
Why 3 Biotechs Upgraded their EDC to Veeva
Support for complex trials without reliance on custom functions, no downtime during amendments, and faster study build and close out. Emerging biotechs are updating their EDC to an innovative system that efficiently supports clinical trials. Learn how